ATE173476T1 - 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica - Google Patents

1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Info

Publication number
ATE173476T1
ATE173476T1 AT91911396T AT91911396T ATE173476T1 AT E173476 T1 ATE173476 T1 AT E173476T1 AT 91911396 T AT91911396 T AT 91911396T AT 91911396 T AT91911396 T AT 91911396T AT E173476 T1 ATE173476 T1 AT E173476T1
Authority
AT
Austria
Prior art keywords
antiarrhythmics
benzoyl
imidazole
piperidine derivatives
agents
Prior art date
Application number
AT91911396T
Other languages
English (en)
Inventor
You-Ling Chou
Paul William Erhardt
Alfred Arthur Hagedorn
John W Lampe
William Carl Lumma Jr
Thomas Kenneth Morgan
Jay Ross Wiggins
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE173476T1 publication Critical patent/ATE173476T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT91911396T 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica ATE173476T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,980 US5189036A (en) 1990-06-20 1990-06-20 Imidazolylbenzoyl substituted heterocycles

Publications (1)

Publication Number Publication Date
ATE173476T1 true ATE173476T1 (de) 1998-12-15

Family

ID=24157703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911396T ATE173476T1 (de) 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Country Status (6)

Country Link
US (1) US5189036A (de)
EP (1) EP0537201B1 (de)
JP (1) JPH05509303A (de)
AT (1) ATE173476T1 (de)
DE (1) DE69130505D1 (de)
WO (1) WO1991019709A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801650A4 (de) * 1994-12-22 1998-05-06 Smithkline Beecham Corp Fibrinogenrezeptor-antagonisten
GB2327418A (en) * 1997-07-18 1999-01-27 Rhone Poulenc Agriculture Derivatives of 2-benzoylcyclohexane-1,3-dione
US5977376A (en) * 1997-07-18 1999-11-02 Rhone-Poulenc Agriculture Limited Herbicidal 2-benzoylcyclohexane-1,3-diones and related compounds
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
PL364625A1 (en) 2001-02-23 2004-12-13 Merck & Co, Inc. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
CA2443108A1 (en) 2001-04-03 2002-10-17 Merck & Co. Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
TW200825072A (en) * 2006-10-20 2008-06-16 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors
US20080200444A1 (en) * 2006-10-20 2008-08-21 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
BRPI0721451A2 (pt) * 2007-03-13 2014-03-25 Arete Therapeutics Inc Compostos de 4-piperidiniluréia como inibidores de epóxido hidrolase solúvel
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804662A (en) * 1987-05-05 1989-02-14 Schering A.G. Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics

Also Published As

Publication number Publication date
WO1991019709A1 (en) 1991-12-26
EP0537201A1 (de) 1993-04-21
DE69130505D1 (de) 1998-12-24
EP0537201B1 (de) 1998-11-18
US5189036A (en) 1993-02-23
JPH05509303A (ja) 1993-12-22

Similar Documents

Publication Publication Date Title
ATE173476T1 (de) 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
DE69226953D1 (de) Verwendung von tetrahydrocarbazolderivaten als 5ht1-rezeptor-agonisten
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
DK394589A (da) 3-heterocyclyl-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-alkan-2-ol-forbindelser, deres anvendelse til fremstilling af antifungale midler, farmaceutiske praeparater indeholdende forbindelserne og mellemprodukter ved fremstilling af forbindelserne
DE69024281D1 (de) Azole als Pestizide
ES8505364A1 (es) Un procedimiento para la preparacion 1-imidazoles y 1h-1, 2, 4-triazoles
DE68928262D1 (de) Derivate von Alkanolaminen als kardiovaskuläre Mittel
FI925415A0 (fi) Framstaellning av substituerade piperidiner
ATE102191T1 (de) Substituierte 4-(1h-imidazol-1-yl>benzamide als antiarrhythmische mittel.
ITMI913374A0 (it) Nuovi composti tetrametilpiperidinici atti all'impiego come stabilizzanti per materiali organici
DE59200199D1 (de) Fungizide Mischung.
NO900019D0 (no) Piperidiner og fremgangsmaate til fremstilling derav.
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
DK0439265T3 (da) Hidtil ukendte 1,3-dicarbonylforbindelser og anvendelse deraf
DK686088D0 (da) 2-phenyl-3-(piperazin-1-yl)-1-(1h-1,2,4-triazol-1-yl) propan-2-ol-forbindelser
ITMI931685A0 (it) Nuovi derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
NO20033184D0 (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
DE69100517D1 (de) Polyethyleneiminphosphonatderivate als Dispergiermittel enthaltende Zementzusammensetzungen.
ATE139557T1 (de) Zusammensetzungen die 1,1,1,2-tetrafluoroethan enthalten und verwendung von diesen zusammensetzungen
FI915056A7 (fi) Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
DE59204301D1 (de) Fungizide Wirkstoffkombinationen.
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
DE69526668D1 (de) Heterocyclisch substituierte propensäure derivate als nmda antagonisten
DK151082A (da) Fungicidt middel indeholdende triazolylderivater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties